Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2026-01-01 @ 7:55 PM
Study NCT ID:
NCT06375161
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-04-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.
Sponsor:
Shanghai Tongji Hospital, Tongji University School of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CD19-CN-A6
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None